T.S.G. ASSOCIATES LLP

T.S.G. Associates LLP specializes in portable stretchers, which are designed for patient transport and mobility support. These devices are intended for clinical and emergency settings to ensure safe movement of patients between locations. The focus is on a single category of device, making their offerings straightforward for healthcare providers needing reliable transport solutions.

T.S.G. Associates LLP is based in the United States. Since the company operates within the U.S., its devices are subject to FDA regulations. The FDA’s Unique Device Identifier (UDI) database includes T.S.G.’s products, which helps ensure traceability and compliance with U.S. medical device requirements. The location also influences which registries and regulatory pathways apply to their devices.

T.S.G. Associates LLP’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is critical because it provides a standardized way to identify medical devices, ensuring transparency in supply chains, tracking recalls, and verifying compliance with U.S. regulatory standards. Listing in the UDI database helps healthcare providers and regulators confirm the legitimacy and classification of the devices in use.

T.S.G. Associates LLP’s portable stretchers fall under FDA’s Class I regulatory category. Class I devices are generally considered the lowest risk, often involving simple mechanical devices with minimal risk to users. This classification means they typically require less stringent premarket review, though compliance with general controls (like labeling and manufacturing practices) remains mandatory. The classification reflects the relatively straightforward purpose of these stretchers—patient transport—without advanced features or higher-risk components.